Cleanser Manufacturing Process: From Formula to Filled Goods

Cleanser development remains one of the most requested categories in our OEM/ODM pipeline, and formulas built around Tranexamic Acid continue to lead briefs that target brightening and even skin tone. This guide explains how cleanser is engineered, which variables matter most during scale-up, and how brands can move from concept to a shelf-ready product without costly reformulation.

Tranexamic Acid is widely used in cleanser formulations for dark-spot care. In practical terms it interrupts pigment pathways for a more even complexion. For brand owners the important question is not whether the ingredient works, but at what concentration it stays stable, compatible and pleasant to use. We typically evaluate Tranexamic Acid across a dosage ladder, then lock the level where sensory performance and claim support meet cost targets.

A well-built cleanser positioned on brightening and even skin tone reduces the look of dullness and dark spots. The benefit story is strongest when three layers work together:

• Active system: Tranexamic Acid delivers the primary performance signal.
• Supporting matrix: humectants, emollients and rheology modifiers keep the cleanser comfortable on skin.
• Delivery and preservation: the preservative system and packaging protect the formula through its shelf life.

Our laboratory starts from your positioning brief, then screens Tranexamic Acid against the base you prefer. We test pH windows, viscosity targets, fragrance compatibility and packaging interaction, because a cleanser that performs in the beaker can still fail in tubes, foaming pumps and jars. Stability is verified under heat, cold and cycling conditions, and we repeat microbial challenge testing before any formula is released for scale-up.

Once the core cleanser is approved, most brands extend into a routine: a companion cleanser, a treatment step and a maintenance moisturiser that repeats the Tranexamic Acid story at a different intensity. This approach raises average order value and keeps the ingredient narrative consistent across the shelf. Packaging is usually standardised across the line so that cartons, labels and inserts share the same visual language.

Every Cleanser batch is produced under GMP-compliant manufacturing with retained samples and a certificate of analysis. For shipments into Latin America we prepare the technical file your importer will request, including safety assessment, labelling review and restricted-substance screening. Documentation is assembled during development rather than after production, which is the single most effective way to avoid launch delays.

GuangDong Kangmeihui Cosmetics Co., Ltd. combines formulation, component sourcing, filling and export documentation under one roof. That means a cleanser brief does not get handed between disconnected suppliers, and decisions on Tranexamic Acid dosage, packaging and testing are made against the same timeline. Whether you are launching your first private label or adding a line extension, the goal is the same: a repeatable product that performs identically batch after batch.